What is Leerink Partnrs’ Estimate for SAGE Q1 Earnings?
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for Sage Therapeutics in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of ($1.03) for the quarter. […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for Sage Therapeutics in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of ($1.03) for the quarter. […]
